127 related articles for article (PubMed ID: 29886553)
21. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
[TBL] [Abstract][Full Text] [Related]
22. Quantitative detection of grey and white matter amyloid pathology using a combination of K114 and CRANAD-3 fluorescence.
Stepanchuk AA; Barber PA; Lashley T; Joseph JT; Stys PK
Neurobiol Dis; 2021 Dec; 161():105540. PubMed ID: 34751140
[TBL] [Abstract][Full Text] [Related]
23. Characterization of Proteins Present in Isolated Senile Plaques from Alzheimer's Diseased Brains by MALDI-TOF MS with MS/MS.
Kelley AR; Perry G; Bach SBH
ACS Chem Neurosci; 2018 Apr; 9(4):708-714. PubMed ID: 29301075
[TBL] [Abstract][Full Text] [Related]
24. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
25. Elimination of amyloid precursor protein in senile plaques in the brain of a patient with Alzheimer-type dementia and Down syndrome.
Arai Y; Iwasaki Y; Suzuki T; Ide S; Kaga M
Brain Dev; 2019 Jan; 41(1):106-110. PubMed ID: 30086988
[TBL] [Abstract][Full Text] [Related]
26. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
27. Cost-effective elimination of lipofuscin fluorescence from formalin-fixed brain tissue by white phosphor light emitting diode array.
Sun Y; Chakrabartty A
Biochem Cell Biol; 2016 Dec; 94(6):545-550. PubMed ID: 27824490
[TBL] [Abstract][Full Text] [Related]
28. PET imaging of amyloid in Alzheimer's disease.
Nordberg A
Lancet Neurol; 2004 Sep; 3(9):519-27. PubMed ID: 15324720
[TBL] [Abstract][Full Text] [Related]
29. A Smart Near-Infrared Fluorescence Probe for Selective Detection of Tau Fibrils in Alzheimer's Disease.
Seo Y; Park KS; Ha T; Kim MK; Hwang YJ; Lee J; Ryu H; Choo H; Chong Y
ACS Chem Neurosci; 2016 Nov; 7(11):1474-1481. PubMed ID: 27576176
[TBL] [Abstract][Full Text] [Related]
30. 6-Methoxy-indanone derivatives as potential probes for β-amyloid plaques in Alzheimer's disease.
Nan DD; Gan CS; Wang CW; Qiao JP; Wang XM; Zhou JN
Eur J Med Chem; 2016 Nov; 124():117-128. PubMed ID: 27565554
[TBL] [Abstract][Full Text] [Related]
31. Picture imperfect: Going beyond imaging amyloid in Alzheimer's disease.
Kincaid E
Nat Med; 2016 Oct; 22(10):1067-1068. PubMed ID: 27711060
[No Abstract] [Full Text] [Related]
32. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of aluminium and silicon in lipofuscin granules.
Tokutake S; Oyanagi S
Gerontology; 1995; 41 Suppl 2():131-44. PubMed ID: 8821327
[TBL] [Abstract][Full Text] [Related]
34. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy.
Schmidt ML; Robinson KA; Lee VM; Trojanowski JQ
Am J Pathol; 1995 Aug; 147(2):503-15. PubMed ID: 7639340
[TBL] [Abstract][Full Text] [Related]
35. Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains.
Dudeffant C; Vandesquille M; Herbert K; Garin CM; Alves S; Blanchard V; Comoy EE; Petit F; Dhenain M
Sci Rep; 2017 Jul; 7(1):4955. PubMed ID: 28694463
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
Lee I; Yang J; Lee JH; Choe YS
Bioorg Med Chem Lett; 2011 Oct; 21(19):5765-9. PubMed ID: 21885280
[TBL] [Abstract][Full Text] [Related]
37. Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.
Ikonomovic MD; Buckley CJ; Heurling K; Sherwin P; Jones PA; Zanette M; Mathis CA; Klunk WE; Chakrabarty A; Ironside J; Ismail A; Smith C; Thal DR; Beach TG; Farrar G; Smith AP
Acta Neuropathol Commun; 2016 Dec; 4(1):130. PubMed ID: 27955679
[TBL] [Abstract][Full Text] [Related]
38. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?
Nordberg A
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1540-3. PubMed ID: 15372212
[No Abstract] [Full Text] [Related]
39. Is amyloid plaque imaging the key to monitoring brain pathology of Alzheimer's disease in vivo?
Hardy J
Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1539-40. PubMed ID: 15372211
[No Abstract] [Full Text] [Related]
40. A study of the morphology and distribution of amyloid beta protein immunoreactive plaque and related lesions in the brains of Alzheimer's disease and adult Down's syndrome.
Ikeda S; Allsop D; Glenner GG
Prog Clin Biol Res; 1989; 317():313-23. PubMed ID: 2532370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
